Targretin oral (bexarotene oral) / ReXceptor  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Targretin oral (bexarotene oral) / ReXceptor
NCT00125372: Study of Tarceva and Targretin in Stage I-II Lung Cancer

Completed
N/A
12
US
erlotinib (Tarceva) and bexarotene (Targretin), Tarceva, Targretin
Dartmouth-Hitchcock Medical Center, Ligand Pharmaceuticals, Genentech, Inc.
Carcinoma, Non-small-cell Lung
08/10
08/10

Download Options